L Price

2.2k total citations
47 papers, 1.6k citations indexed

About

L Price is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, L Price has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 20 papers in Pediatrics, Perinatology and Child Health and 19 papers in Molecular Biology. Recurrent topics in L Price's work include Chemotherapy-induced organ toxicity mitigation (24 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Renal and related cancers (12 papers). L Price is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (24 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Renal and related cancers (12 papers). L Price collaborates with scholars based in United Kingdom, United States and China. L Price's co-authors include Andrew D.J. Pearson, Alan V. Boddy, Roderick Skinner, Ruth Wyllie, Alan Craft, Michael Cole, S. Murray Yule, Malcolm Coulthard, Jeffrey R. Idle and Martin English and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

L Price

45 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Price United Kingdom 25 660 520 516 372 313 47 1.6k
Ruth Wyllie United Kingdom 14 345 0.5× 257 0.5× 192 0.4× 185 0.5× 160 0.5× 28 771
William R. Crom United States 22 194 0.3× 533 1.0× 445 0.9× 582 1.6× 556 1.8× 37 1.7k
Marshall P. Goren United States 18 368 0.6× 131 0.3× 203 0.4× 118 0.3× 198 0.6× 35 797
Detlef Lang Germany 21 260 0.4× 198 0.4× 462 0.9× 95 0.3× 337 1.1× 40 1.5k
S. Meijer Netherlands 19 272 0.4× 129 0.2× 208 0.4× 99 0.3× 212 0.7× 53 959
Mario Bargetzi Switzerland 26 686 1.0× 213 0.4× 324 0.6× 232 0.6× 813 2.6× 91 2.3k
Guilin Qiao United States 20 898 1.4× 113 0.2× 338 0.7× 159 0.4× 272 0.9× 33 1.8k
Barbara Mason New Zealand 21 1.2k 1.7× 101 0.2× 278 0.5× 390 1.0× 393 1.3× 36 2.4k
Donald I. Moel United States 15 212 0.3× 205 0.4× 192 0.4× 110 0.3× 114 0.4× 34 938
Martin Howard United Kingdom 18 91 0.1× 370 0.7× 189 0.4× 446 1.2× 314 1.0× 33 1.2k

Countries citing papers authored by L Price

Since Specialization
Citations

This map shows the geographic impact of L Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Price more than expected).

Fields of papers citing papers by L Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Price. The network helps show where L Price may publish in the future.

Co-authorship network of co-authors of L Price

This figure shows the co-authorship network connecting the top 25 collaborators of L Price. A scholar is included among the top collaborators of L Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Price. L Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Jonathan, Dipayan Mitra, L Price, et al.. (2011). The importance of biopsy following radiological diagnosis of relapsed medulloblastoma. British Journal of Neurosurgery. 26(4). 542–544.
2.
Skinner, Roderick, et al.. (2009). Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors. European Journal of Cancer. 45(18). 3213–3219. 91 indexed citations
3.
Chinnaswamy, Girish, Michael Cole, Alan V. Boddy, et al.. (2008). Estimation of renal function and its potential impact on carboplatin dosing in children with cancer. British Journal of Cancer. 99(6). 894–899. 9 indexed citations
4.
Cole, Michael, L Price, Sue Picton, et al.. (2006). A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer. Pediatric Blood & Cancer. 48(7). 687–695. 19 indexed citations
5.
Price, L, Michael J. Tilby, Dianne Ford, et al.. (2005). Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer. British Journal of Cancer. 92(9). 1626–1635. 11 indexed citations
6.
Cole, Michael, L Price, M.J. Keir, et al.. (2004). Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics. British Journal of Cancer. 90(1). 60–64. 28 indexed citations
7.
Parker, Katrina, David T. Wyatt, Sandra L. Blethen, Joyce Baptista, & L Price. (2003). Screening girls with turner syndrome: the national cooperative growth study experience. The Journal of Pediatrics. 143(1). 133–135. 20 indexed citations
8.
Bailey, Simon, Ann Roberts, Christina Brock, et al.. (2002). Nephrotoxicity in survivors of Wilms' tumours in the North of England. British Journal of Cancer. 87(10). 1092–1098. 38 indexed citations
9.
English, Martin, R Skinner, A D Pearson, et al.. (1999). Dose-related nephrotoxicity of carboplatin in children. British Journal of Cancer. 81(2). 336–341. 62 indexed citations
10.
Skinner, Roderick, et al.. (1998). Cisplatin dose rate as a risk factor for nephrotoxicity in children. British Journal of Cancer. 77(10). 1677–1682. 82 indexed citations
11.
Skinner, Roderick, et al.. (1997). The influence of ifosfamide scheduling on acute nephrotoxicity in children. British Journal of Cancer. 75(9). 1356–1359. 7 indexed citations
12.
Peng, Bo, Martin English, Alan V. Boddy, et al.. (1997). Cisplatin pharmacokinetics in children with cancer. European Journal of Cancer. 33(11). 1823–1828. 40 indexed citations
13.
Boddy, Alan V., S. Murray Yule, Ruth Wyllie, et al.. (1996). Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration. Cancer Chemotherapy and Pharmacology. 38(2). 147–154. 27 indexed citations
14.
Skinner, Roderick, Andrew D.J. Pearson, Martin English, et al.. (1996). Risk factors for ifosfamide nephrotoxicity in children. The Lancet. 348(9027). 578–580. 61 indexed citations
15.
Hogarth, Linda, Martin English, L Price, et al.. (1996). The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine. Cancer Chemotherapy and Pharmacology. 37(5). 479–485. 8 indexed citations
16.
Craft, Alan, et al.. (1995). Granisetron as antiemetic therapy in children with cancer. Medical and Pediatric Oncology. 25(1). 28–32. 17 indexed citations
17.
Boddy, Alan V., S. Murray Yule, Ruth Wyllie, et al.. (1995). Comparison of continuous infusion and bolus administration of ifosfamide in children. European Journal of Cancer. 31(5). 785–790. 35 indexed citations
18.
Newell, David R., A D Pearson, Kathryn Balmanno, et al.. (1993). Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.. Journal of Clinical Oncology. 11(12). 2314–2323. 113 indexed citations
19.
Tasso, M, Alan V. Boddy, L Price, et al.. (1992). Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients. Cancer Chemotherapy and Pharmacology. 30(3). 207–211. 41 indexed citations
20.
Skinner, Roderick, et al.. (1989). Hypophosphataemic rickets after ifosfamide treatment in children.. BMJ. 298(6687). 1560–1561. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Wyllie Breakdown of academic impact, for papers by William R. Crom Breakdown of academic impact, for papers by Marshall P. Goren Breakdown of academic impact, for papers by Detlef Lang Breakdown of academic impact, for papers by S. Meijer Breakdown of academic impact, for papers by Mario Bargetzi Breakdown of academic impact, for papers by Guilin Qiao Breakdown of academic impact, for papers by Barbara Mason Breakdown of academic impact, for papers by Donald I. Moel Breakdown of academic impact, for papers by Martin Howard
Rankless by CCL
2026